NCI Precision Medicine Study Hones in on Cancer Remission
Researchers say a non-chemotherapy treatment is causing more cancer patients to experience full remission.
A recent National Cancer Institute study shows that a new targeted therapy can help prolong the time cancer patients are in remission. Called the ViPOR regimen, the non-chemotherapy treatment shrinks tumors of those who suffer from B-cell lymphoma.
Dr. Christopher Melani, associate research physician with the Lymphoid Malignancies Branch in the Center for Cancer Research at NCI, highlights the importance of combining five therapies and administering them during a fixed cycle to maximize drug synergy and make tumors disappear.
He also shares details about the second phase of the study that is expected to take place later this year as well as how precision medicine could potentially lead to a cure for all types of cancer.
-
Dr. Christopher Melani Associate Research Physician, Lymphoid Malignancies Branch, Center for Cancer Research NCI
-
How AI and Data Are Shaping the Future of the Coast Guard
Deputy CIO Brian Campo says USCG is focusing its AI on efficiency, learning from peers and simplifying regulations for the maritime community.
17m watch -
NCI's Tech-Based Therapy Helps Patients Battle HPV-Linked Respiratory Disease
A new tech-based therapy is helping NCI treat patients who suffer from a respiratory illness associated with HPV.
23m listen -
CDC's Strategic Vision for Faster, Smarter Public Health Response
Dr. Jennifer Layden, a key architect of the CDC's Public Health Data Strategy, shares how modern technology is transforming disease detection and response.
9m listen -
Navy’s MOSA 1.0 Boosts Innovation, Interoperability
The Navy’s Modular Open Systems Architecture enables rapid prototyping, tech adoption and sharing of best practices across the Defense Department.
14m watch
